• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Primary adenocarcinoma of the upper oesophagus.

作者信息

Danoff B, Cooper J, Klein M

出版信息

Clin Radiol. 1978 Sep;29(5):519-22. doi: 10.1016/s0009-9260(78)80042-7.

DOI:10.1016/s0009-9260(78)80042-7
PMID:710037
Abstract

Adenocarcinoma of the upper one-third of the oesophagus is an uncommon entity. A review of the literature reveals 20 reported cases. This paper reports an additional case. The lesion may arise from oesophageal glands, foci of ectopic gastric mucosa, or a Barrett's oesophagus. In contrast with squamous cell carcinomas submucosal spread is not prominent; however, transverse penetration through the oesophageal wall is common. The prognosis is grave. Treatment modalities that have been employed include supportive care, surgery alone, pre-operative radiation therapy and surgery and radiation therapy alone. Survival statistics produced by these various regimens are similar. There is little documented evidence for the radioresponsiveness of primary adenocarcinoma of the oesophagus. The case described demonstrates marked tumour regression following a course of external radiotherapy as shown by serial oesophagrams. Optimum treatment for adenocarcinoma of the upper oesophagus remains to be determined. It is felt that the role of radiation therapy should be further evaluated.

摘要

相似文献

1
Primary adenocarcinoma of the upper oesophagus.
Clin Radiol. 1978 Sep;29(5):519-22. doi: 10.1016/s0009-9260(78)80042-7.
2
Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.在发生食管腺癌的巴雷特食管患者中,非甾体类抗炎药的日常使用频率较低。
Aliment Pharmacol Ther. 2004 Sep 15;20(6):645-55. doi: 10.1111/j.1365-2036.2004.02150.x.
3
Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.160例巴雷特食管或巴雷特腺癌患者的幽门螺杆菌感染率
Aust N Z J Surg. 2000 Jan;70(1):26-33. doi: 10.1046/j.1440-1622.2000.01737.x.
4
Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery.食管癌的根治性放疗:手术的有效替代方案
Radiother Oncol. 1998 Jul;48(1):15-21. doi: 10.1016/s0167-8140(98)00037-1.
5
Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.在巴雷特食管的发育异常-癌序列中,Akt的激活增加,这有助于增殖增加和细胞凋亡抑制:一项组织病理学和功能研究。
BMC Cancer. 2007 Jun 8;7:97. doi: 10.1186/1471-2407-7-97.
6
Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.巴雷特食管长度与癌症风险:来自一大群早期食管腺癌患者的启示。
Gut. 2016 Feb;65(2):196-201. doi: 10.1136/gutjnl-2015-309220. Epub 2015 Jun 25.
7
Barrett's oesophagus: Current controversies.巴雷特食管:当前的争议。
World J Gastroenterol. 2017 Jul 28;23(28):5051-5067. doi: 10.3748/wjg.v23.i28.5051.
8
GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.GATA6在巴雷特食管和食管腺癌中的表达。
Dig Liver Dis. 2015 Jan;47(1):73-80. doi: 10.1016/j.dld.2014.09.014. Epub 2014 Oct 16.
9
Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.饮食炎症指数与反流性食管炎、巴雷特食管和食管腺癌风险:一项基于人群的病例对照研究。
Br J Nutr. 2017 May;117(9):1323-1331. doi: 10.1017/S0007114517001131. Epub 2017 Jun 2.
10
Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?巴雷特食管的监测:针对高危人群的策略能否降低食管腺癌的死亡率?
Endoscopy. 2006 Feb;38(2):162-9. doi: 10.1055/s-2005-921184.

引用本文的文献

1
A 14-Year Study of 398 Esophageal Adenocarcinomas Diagnosed Among 156,256 EGDs Performed at Two Large Hospitals: An Inlet Patch Is Proposed as a Significant Risk Factor for Proximal Esophageal Adenocarcinoma.在两家大医院进行的 156256 次内镜检查中诊断出 398 例食管腺癌:14 年研究结果表明,入口补丁被认为是近端食管腺癌的一个重要危险因素。
Dig Dis Sci. 2018 Feb;63(2):452-465. doi: 10.1007/s10620-017-4878-2. Epub 2017 Dec 16.
2
Adenocarcinoma of the cervical esophagus arising from ectopic gastric mucosa: report of two cases and review of the literature.起源于异位胃黏膜的颈段食管腺癌:2例报告并文献复习
Clin J Gastroenterol. 2015 Dec;8(6):367-76. doi: 10.1007/s12328-015-0610-y.
3
Intramucosal adenocarcinoma arising from ectopic gastric mucosa in the upper esophagus treated successfully with endoscopic mucosal resection.
内镜黏膜下剥离术成功治疗起源于食管上段异位胃黏膜的黏膜内腺癌。
J Gastrointest Cancer. 2014 Dec;45 Suppl 1:201-4. doi: 10.1007/s12029-014-9628-5.
4
Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus.起源于胸段上段食管异位胃黏膜的混合性腺(神经)内分泌癌。
World J Surg Oncol. 2013 Sep 4;11:218. doi: 10.1186/1477-7819-11-218.
5
Non-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA.利用循环游离DNA中的基因变化对食管癌进行非侵入性检测。
Avicenna J Med Biotechnol. 2012 Jan;4(1):3-13.
6
Primary esophageal adenocarcinoma arising from heterotopic gastric mucosa: report of a case.原发性食管腺癌源于异位胃黏膜:病例报告。
Surg Today. 2013 Apr;43(4):446-51. doi: 10.1007/s00595-012-0206-9. Epub 2012 Jun 17.
7
A case of esophageal adenocarcinoma arising from the ectopic gastric mucosa in the thoracic esophagus.一例起源于胸段食管异位胃黏膜的食管腺癌。
Rare Tumors. 2010 Mar 31;2(1):e5. doi: 10.4081/rt.2010.e5.
8
Adenocarcinoma of the upper esophagus arising in cervical ectopic gastric mucosa: rare evidence of malignant potential of so-called "inlet patch".
Dig Dis Sci. 1998 Apr;43(4):901-7. doi: 10.1023/a:1018855223225.
9
Cervical esophageal web associated with a patch of heterotopic gastric mucosa.伴有一片异位胃黏膜的颈段食管蹼。
Abdom Imaging. 1993;18(3):227-8. doi: 10.1007/BF00198108.
10
Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction.
Ann Surg Oncol. 1994 Jan;1(1):5-10. doi: 10.1007/BF02303535.